文献速递眼底病与葡萄膜炎

使用生成式、判别式和自监督深度学习检测视网膜疾病中的异常

Detecting Anomalies in Retinal Diseases Using Generative, Discriminative, and Self-supervised Deep Learning.
PubMed 文献 · JAMA Ophthalmol · 2022-01-01

本研究基于EyePACS公开数据集中的88 692张高分辨率视网膜图像(来自44 346人),构建16种异常检测器变体,仅用非转诊糖尿病视网膜病变图像训练,测试其检测转诊糖尿病视网膜病变的能力。表现最佳的异常检测器采用自监督网络嵌入方法,受试者工作特征曲线下面积为0.808(95% CI,0.789-0.827)。作者认为异常检测技术有助于在训练数据仅含非转诊病变时识别有无转诊糖尿病视网膜病变的图像。

要点

  • 仅用非转诊糖尿病视网膜病变图像训练,异常检测器可识别转诊糖尿病视网膜病变。
  • 最佳异常检测器采用自监督网络嵌入方法,AUC为0.808(95% CI,0.789-0.827)。
  • 作者认为异常检测器可能用于更广泛场景下的视网膜疾病检测。

核心结论

  • 当训练视网膜诊断系统时缺乏异常(患病)数据(本研究中为转诊糖尿病视网膜病变),仅使用非转诊糖尿病视网膜病变训练,异常检测技术有助于识别有无转诊糖尿病视网膜病变的图像。
  • 作者认为异常检测器可能用于更广泛场景下的视网膜疾病检测,并可能在人群视网膜疾病筛查或识别新疾病及表型分析或检测常见视网膜疾病的不寻常表现中发挥作用。

研究设计与样本

  • 研究使用EyePACS公开数据集中的高分辨率视网膜图像,图像对应标签为0至4,代表不同严重程度的糖尿病视网膜病变。
  • 设计了16种异常检测器变体。
  • 构建替代问题进行评估:仅使用非转诊糖尿病视网膜病变(即无糖尿病黄斑水肿且无糖尿病视网膜病变或轻至中度非增殖性糖尿病视网膜病变)的视网膜图像训练人工智能系统,使用非转诊和转诊糖尿病视网膜病变(包括糖尿病黄斑水肿或增殖性糖尿病视网膜病变)的图像测试系统检测视网膜疾病。
  • 共分析88 692张高分辨率视网膜图像,来自44 346名不同严重程度糖尿病视网膜病变的个体。

主要发现

  • 所有异常检测器中表现最佳者的受试者工作特征曲线下面积为0.808(95% CI,0.789-0.827),采用涉及自监督网络的嵌入方法获得。
  • 异常检测器通过常用性能指标评估,包括受试者工作特征曲线下面积、F1分数和准确率。

关键数值与推荐

  • 异常检测器评估指标包括受试者工作特征曲线下面积、F1分数和准确率。
  • 最佳异常检测器的受试者工作特征曲线下面积为0.808(95% CI,0.789-0.827)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Anomaly detectors could be pursued for retinal diagnoses based on artificial intelligence systems that may not have access to training examples for all retinal diseases in all phenotypic presentations. Possible applications could include screening of population for any retinal disease rather than a specific disease such as diabetic retinopathy, detection of novel retinal diseases or novel presentations of common retinal diseases, and detection of rare diseases with little or no data available for training. OBJECTIVE: To study the application of anomaly detection to retinal diseases. DESIGN, SETTING, AND PARTICIPANTS: High-resolution retinal images from the publicly available EyePACS data set with fundus images with a corresponding label ranging from 0 to 4 for representing different severities of diabetic retinopathy. Sixteen variants of anomaly detectors were designed. For evaluation, a surrogate problem was constructed, using diabetic retinopathy images, in which only retinas with nonreferable diabetic retinopathy, ie, no diabetic macular edema, and no diabetic retinopathy or mild to moderate nonproliferative diabetic retinopathy were used for training an artificial intelligence system, but both nonreferable and referable diabetic retinopathy (including diabetic macular edema or proliferative diabetic retinopathy) were used to test the system for detecting retinal disease. MAIN OUTCOMES AND MEASURES: Anomaly detectors were evaluated by commonly accepted performance metrics, including area under the receiver operating characteristic curve, F1 score, and accuracy. RESULTS: A total of 88 692 high-resolution retinal images of 44 346 individuals with varying severity of diabetic retinopathy were analyzed. The best performing across all anomaly detectors had an area under the receiver operating characteristic of 0.808 (95% CI, 0.789-0.827) and was obtained using an embedding method that involved a self-supervised network. CONCLUSIONS AND RELEVANCE: This study suggests when abnormal (diseased) data, ie, referable diabetic retinopathy in this study, were not available for training of retinal diagnostic systems wherein only nonreferable diabetic retinopathy was used for training, anomaly detection techniques were useful in identifying images with and without referable diabetic retinopathy. This suggests that anomaly detectors may be used to detect retinal diseases in more generalized settings and potentially could play a role in screening of populations for retinal diseases or identifying novel diseases and phenotyping or detecting unusual presentations of common retinal diseases.

来源:JAMA Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Burlina P, Paul W, Liu TYA, et al. Detecting Anomalies in Retinal Diseases Using Generative, Discriminative, and Self-supervised Deep Learning. JAMA Ophthalmol. 2022. PMID: 34967890. doi:10.1001/jamaophthalmol.2021.5557

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。